Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vascular Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 157 articles: HTML format

Single Articles

March 2023
1. CIARDETTI N, Nardi G, Di Mario C
   Direct high-frequency intravascular ultrasound visualization of drug delivery after paclitaxel urea eluting balloon angioplasty.
   Eur Heart J. 2023;44:1096.
   PubMed    
   
   
   
2. HONDA Y, Nishihira K, Shibata Y, Asada Y, et al
   Early-phase restenosis following directional coronary atherectomy and paclitaxel-coated balloon angioplasty: a histopathological analysis.
   Eur Heart J. 2023;44:1098.
   PubMed    
   
   
   
3. KOECKERLING D, Raguindin PF, Kastrati L, Bernhard S, et al
   Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.
   Eur Heart J. 2023;44:935-950.
   PubMed     Abstract available
   
   
   
4. CAPODANNO D, Greco A
   Dual antiplatelet therapy in patients at high bleeding risk: less is more-more or less.
   Eur Heart J. 2023;44:969-971.
   PubMed    
   
   
   
5. RYLSKI B, Schilling O, Czerny M
   Acute aortic dissection: evidence, uncertainties, and future therapies.
   Eur Heart J. 2023;44:813-821.
   PubMed     Abstract available
   
   
   
6. MA N, Li L, Tang X
   A rare case of a dorsal mass caused by descending thoracic aortic dissection.
   Eur Heart J. 2023;44:780.
   PubMed    
   
   
   February 2023
7. GERSH BJ, De Mets D
   Revascularization in ischaemic cardiomyopathy: how to interpret current evidence.
   Eur Heart J. 2023;44:365-367.
   PubMed    
   
   
   January 2023
8. CAO L, Zhang H, Guo W
   First in man: sealing the distal re-entry tears of aortic dissection after thoracic endovascular aortic repair by an ENDOPATCH system.
   Eur Heart J. 2023;44:237.
   PubMed    
   
   
   
9. OMRAN H
   Troponin for risk stratification after CABG: just one piece of the puzzle.
   Eur Heart J. 2023;44:163-164.
   PubMed    
   
   
   
10. CHEN T, Zhou H, Guo J, Chen Y, et al
    Intravascular ultrasound and ultrasonic flow ratio-guided zero-contrast rotational atherectomy for calcified coronary lesions.
    Eur Heart J. 2023;44:166.
    PubMed    
    
    
    December 2022
11. LEE JM, Kim HK, Park KH, Choo EH, et al
    Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
    Eur Heart J. 2022 Dec 20:ehac763. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. NISHIHIRA K, Shibata Y, Asada Y
    Intraplaque haemorrhage in rapidly progressing coronary atheroma: insights from histopathological analysis of atherectomy specimens.
    Eur Heart J. 2022;43:4964.
    PubMed    
    
    
    
13. COUGHLAN JJ, Ibanez B
    Reperfusion in ST-elevation myocardial infarction: delays have dangerous ends.
    Eur Heart J. 2022 Dec 14:ehac723. doi: 10.1093.
    PubMed    
    
    
    
14. VERGALLO R, Patrono C
    A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction.
    Eur Heart J. 2022 Dec 7:ehac732. doi: 10.1093.
    PubMed    
    
    
    
15. COSTA F, Montalto C, Branca M, Hong SJ, et al
    Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.
    Eur Heart J. 2022 Dec 7:ehac706. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. JAMAL J, Idris H, Faour A, Yang W, et al
    Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.
    Eur Heart J. 2022 Dec 2:ehac661. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. HAN Y
    Chinese guidelines for percutaneous coronary intervention in patients with left main bifurcation disease.
    Eur Heart J. 2022 Dec 2:ehac625. doi: 10.1093.
    PubMed    
    
    
    November 2022
18. KITE TA, Bountziouka V, Ladwiniec A
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
    Eur Heart J. 2022;43:4661.
    PubMed    
    
    
    
19. ALADIN AI, Zhang C, Waksman R
    Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome.
    Eur Heart J. 2022;43:4660.
    PubMed    
    
    
    
20. MOTOVSKA Z, Akin I
    The art of selection in coronary bypass grafting.
    Eur Heart J. 2022;43:4653-4656.
    PubMed    
    
    
    
21. TAGGART DP, Audisio K, Gerry S, Robinson NB, et al
    Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial.
    Eur Heart J. 2022;43:4644-4652.
    PubMed     Abstract available
    
    
    
22. VAN DEN BROEK WWA, Ten Berg JM
    Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
    Eur Heart J. 2022;43:4599-4600.
    PubMed    
    
    
    
23. PATHAK S, Lai FY, Miksza J, Petrie MC, et al
    Surgical or Percutaneous Coronary Revascularisation for Heart Failure: An In Silico Model using Routinely Collected Health Data to Emulate a Clinical Trial.
    Eur Heart J. 2022 Nov 9. pii: 6815617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. HEUTS S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, et al
    Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications.
    Eur Heart J. 2022 Nov 7. pii: 6807330. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
25. HEYNE S, Macherey S, Meertens MM, Braumann S, et al
    Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis.
    Eur Heart J. 2022 Oct 27. pii: 6775293. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. VERGALLO R, Volpe M
    Fractional flow reserve or intravascular ultrasound for guiding percutaneous coronary intervention of intermediate coronary stenoses? Sometimes apples and oranges have the same FLAVOUR.
    Eur Heart J. 2022 Oct 26. pii: 6774407. doi: 10.1093.
    PubMed    
    
    
    
27. ARMILLOTTA M, Foa A, Pizzi C
    Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification.
    Eur Heart J. 2022 Oct 20. pii: 6763997. doi: 10.1093.
    PubMed    
    
    
    
28. VERGALLO R, Liuzzo G
    The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
    Eur Heart J. 2022 Oct 10. pii: 6754626. doi: 10.1093.
    PubMed    
    
    
    September 2022
29. ARMSTRONG PW, Bates ER, Gaudino M
    Left main coronary disease: evolving management concepts.
    Eur Heart J. 2022 Sep 29. pii: 6731216. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. VAN DEN ENDEN AJM, Meuwese CL, Van Mieghem NM
    Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism.
    Eur Heart J. 2022 Sep 21. pii: 6710213. doi: 10.1093.
    PubMed    
    
    
    
31. VERGALLO R, Patrono C
    Antiplatelet therapy to prevent graft failure after coronary artery bypass graft: aspirin monotherapy for most, DAPT for selected few.
    Eur Heart J. 2022 Sep 14. pii: 6697011. doi: 10.1093.
    PubMed    
    
    
    
32. SPIRITO A, Cao D, Mehran R
    Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon.
    Eur Heart J. 2022;43:3145-3147.
    PubMed    
    
    
    
33. DRIESSEN RS, van Diemen PA, Raijmakers PG, Knuuti J, et al
    Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study.
    Eur Heart J. 2022;43:3118-3128.
    PubMed     Abstract available
    
    
    
34. KITE TA, Kurmani SA, Bountziouka V, Cooper NJ, et al
    Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2022;43:3148-3161.
    PubMed     Abstract available
    
    
    August 2022
35. UMEI TC, Kishino Y, Kawakami T, Fukuda K, et al
    Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2022 Aug 8. pii: 6658235. doi: 10.1093.
    PubMed    
    
    
    
36. RONG D, Zhang H, Guo W
    Aortic arch aneurysm isolated by percutaneous total endovascular arch replacement.
    Eur Heart J. 2022;43:2905.
    PubMed    
    
    
    July 2022
37. ORTEGA-PAZ L, Angiolillo DJ
    Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention.
    Eur Heart J. 2022 Jul 21. pii: 6647789. doi: 10.1093.
    PubMed    
    
    
    
38. CREA F
    The challenge of risk stratification in aortic aneurysms, congenital heart disease, and coronary bypass surgery.
    Eur Heart J. 2022;43:2343-2346.
    PubMed    
    
    
    
39. GAUDINO M, Farkouh ME, Stone GW
    Left main revascularization: an evidence-based reconciliation.
    Eur Heart J. 2022;43:2421-2424.
    PubMed    
    
    
    
40. RYCHIK J
    You can only change what you measure: an argument for more detailed characterization in the Fontan circulation.
    Eur Heart J. 2022;43:2385-2387.
    PubMed    
    
    
    
41. ELEFTERIADES JA, Zafar MA, Ziganshin BA
    Nationwide collaboration produces valuable data regarding arch and descending aorta.
    Eur Heart J. 2022;43:2370-2372.
    PubMed    
    
    
    
42. INAI K, Inuzuka R, Ono H, Nii M, et al
    Predictors of long-term mortality among perioperative survivors of Fontan operation.
    Eur Heart J. 2022;43:2373-2384.
    PubMed     Abstract available
    
    
    June 2022
43. ZHANG Y, Yang P, Lu C, Hu J, et al
    Hybrid aortic arch repair for unibody single-branched endograft induced retrograde aortic dissection.
    Eur Heart J. 2022;43:2342.
    PubMed    
    
    
    
44. KHAIRY P, Silka MJ, Moore JP, DiNardo JA, et al
    Sudden cardiac death in congenital heart disease.
    Eur Heart J. 2022;43:2103-2115.
    PubMed     Abstract available
    
    
    
45. ZHANG X, Fang Z, Zhang H, Ma X, et al
    Fibromuscular dysplasia: a rare adult case with aortic arch coarctation and bilateral subclavian artery and internal carotid artery stenosis.
    Eur Heart J. 2022 Jun 2. pii: 6599045. doi: 10.1093.
    PubMed    
    
    
    May 2022
46. GANESANANTHAN S, Rajkumar CA, Foley M, Thompson D, et al
    Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Eur Heart J. 2022 May 26. pii: 6593472. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
48. BATRA G, Aktaa S, Wallentin L, Maggioni AP, et al
    Data standards for acute coronary syndrome and percutaneous coronary intervention: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
    Eur Heart J. 2022 Apr 5. pii: 6563567. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
49. CREA F
    Percutaneous coronary intervention vs. coronary artery bypass graft: the saga continues.
    Eur Heart J. 2022;43:1273-1276.
    PubMed    
    
    
    
50. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.
    PubMed    
    
    
    
51. ALMARZOOQ ZI, Yeh RW
    'State of the Art' PCI: bridging the implementation gap.
    Eur Heart J. 2022;43:1317-1319.
    PubMed    
    
    
    
52. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    PubMed     Abstract available
    
    
    
53. HAN Y, Li Y
    Adherence to P2Y12 inhibitors in acute coronary syndrome after a percutaneous coronary intervention: what can we improve?
    Eur Heart J. 2022 Mar 17. pii: 6549760. doi: 10.1093.
    PubMed    
    
    
    
54. TURGEON RD, Koshman SL, Dong Y, Graham MM, et al
    P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications.
    Eur Heart J. 2022 Mar 17. pii: 6549798. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. THYGESEN K, Jaffe AS
    Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting.
    Eur Heart J. 2022 Mar 17. pii: 6549761. doi: 10.1093.
    PubMed    
    
    
    February 2022
56. LIUZZO G, Volpe M
    Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debate.
    Eur Heart J. 2022 Feb 21. pii: 6533241. doi: 10.1093.
    PubMed    
    
    
    
57. OMRAN H, Deutsch MA, Groezinger E, Zittermann A, et al
    High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making.
    Eur Heart J. 2022 Feb 15. pii: 6528587. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. POLZL L, Thielmann M, Cymorek S, Nagele F, et al
    Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.
    Eur Heart J. 2022 Feb 9. pii: 6525341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. ESCANED J, Jaffer FA, Mehilli J, Mehran R, et al
    The year in cardiovascular medicine 2021: interventional cardiology.
    Eur Heart J. 2022;43:377-386.
    PubMed     Abstract available
    
    
    January 2022
60. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    PubMed     Abstract available
    
    
    
61. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.
    PubMed    
    
    
    December 2021
62. WANG R, Serruys PW, Gao C, Hara H, et al
    Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.
    Eur Heart J. 2021;43:56-67.
    PubMed     Abstract available
    
    
    
63. BODEN WE, De Caterina R, Taggart DP
    Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility.
    Eur Heart J. 2021;43:68-70.
    PubMed    
    
    
    
64. BEHRENDT CA
    Higher long-term mortality after endovascular vs. open-surgical revascularization of peripheral artery disease in Australia and New Zealand?
    Eur Heart J. 2021;43:41-43.
    PubMed    
    
    
    
65. PARVAR SL, Ngo L, Dawson J, Nicholls SJ, et al
    Long-term outcomes following endovascular and surgical revascularization for peripheral artery disease: a propensity score-matched analysis.
    Eur Heart J. 2021;43:32-40.
    PubMed     Abstract available
    
    
    
66. LOZANO I, Vegas JM, Rondan J
    Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
    Eur Heart J. 2021;42:4981.
    PubMed    
    
    
    
67. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. CREA F
    Percutaneous coronary interventions: more complex than fixing stenoses.
    Eur Heart J. 2021;42:4607-4611.
    PubMed    
    
    
    
69. NAVARESE EP, Andreotti F
    Cardiac mortality, adequate power, and objective inclusion of the entire evidence are key to accurately define the long-term effect of revascularisation vs. medical therapy alone in stable coronary syndromes.
    Eur Heart J. 2021;42:4699-4700.
    PubMed    
    
    
    
70. WHITE HD
    Cardiac death should be the primary endpoint for revascularization trials and meta-analyses.
    Eur Heart J. 2021;42:4697-4698.
    PubMed    
    
    
    
71. PARKER WAE, Storey RF
    Ticagrelor monotherapy in CKD: better safety at what price?
    Eur Heart J. 2021;42:4694-4696.
    PubMed    
    
    
    
72. ABELLAS-SEQUEIROS M, Pardo Sanz A, Sanchez-Recalde A, Sanmartin-Fernandez M, et al
    Traumatic coronary artery dissection with total occlusion of left descending coronary artery: to stent or not to stent.
    Eur Heart J. 2021;42:4701.
    PubMed    
    
    
    
73. BROWN DL, Boden WE
    Impact of revascularisation on outcomes in chronic coronary syndromes: a new meta-analysis with the same old biases?
    Eur Heart J. 2021;42:4652-4655.
    PubMed    
    
    
    
74. ERLINGE D, Gotberg M
    We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
    Eur Heart J. 2021;42:4669-4670.
    PubMed    
    
    
    November 2021
75. GASBARRINO K, Di Iorio D, Daskalopoulou SS
    Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.
    Eur Heart J. 2021 Nov 26. pii: 6444192. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. EGGERS KM, James SK, Lindahl B
    Myocardial infarction after elective percutaneous coronary intervention-which cardiac troponin cut-off to use?
    Eur Heart J. 2021 Nov 24. pii: 6438090. doi: 10.1093.
    PubMed    
    
    
    
77. MARK N
    Healing the rift over left main revascularization.
    Eur Heart J. 2021;42:4509-4511.
    PubMed    
    
    
    
78. LIUZZO G, Patrono C
    Does abbreviated dual antiplatelet therapy after PCI provide a clinically meaningful trade-off between bleeding and ischaemic events in patients at high risk for bleeding?
    Eur Heart J. 2021;42:4418-4419.
    PubMed    
    
    
    
79. KAWAMURA M, Monta O
    Spontaneous true lumen expansion in chronic type B aortic dissection.
    Eur Heart J. 2021;42:4403.
    PubMed    
    
    
    October 2021
80. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. FERNANDO H, Duong T, Huynh K, Noonan J, et al
    Effects of lignocaine vs. opioids on antiplatelet activity of ticagrelor: the LOCAL trial.
    Eur Heart J. 2021;42:4025-4036.
    PubMed     Abstract available
    
    
    
82. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021;42:4037-4039.
    PubMed    
    
    
    
83. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.
    Eur Heart J. 2021 Oct 11. pii: 6386704. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2021
85. HAN Y
    Long-term outcomes of new-generation coronary stents in China.
    Eur Heart J. 2021 Sep 18. pii: 6372216. doi: 10.1093.
    PubMed    
    
    
    
86. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    PubMed    
    
    
    
87. ERLINGE D, Gotberg M
    We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
    Eur Heart J. 2021 Sep 4. pii: 6364082. doi: 10.1093.
    PubMed    
    
    
    August 2021
88. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    PubMed     Abstract available
    
    
    
89. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    PubMed     Abstract available
    
    
    
90. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. NICHOLLS M
    Mark Nicholls speaks to Professor Eric Durand and Professor Remi Sabatier about Europe's first remote robotic-assisted angioplasty procedure.
    Eur Heart J. 2021;42:3033-3035.
    PubMed    
    
    
    
92. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. CREA F
    Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy.
    Eur Heart J. 2021;42:2973-2985.
    PubMed    
    
    
    
94. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
96. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    
    
    
    
98. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. MADHAVAN MV, Howard JP, Naqvi A, Ben-Yehuda O, et al
    Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
    Eur Heart J. 2021;42:2643-2654.
    PubMed     Abstract available
    
    
    
100. NI B, Gu J, Li M, Shao Y, et al
     Emergent endovascular repair of a huge aortic arch aneurysm with aortopulmonary fistula secondary to Takayasu's arteritis.
     Eur Heart J. 2021;42:2712.
     PubMed    
     
     
     
101. ABDELWAHED YS, Schatz AS, Landmesser U, Skurk C, et al
     'Small bifurcation?' CT myocardial mass volume measurements change therapeutic strategy in coronary artery disease.
     Eur Heart J. 2021;42:2713-2714.
     PubMed    
     
     
     
102. MAMAS MA
     Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
     Eur Heart J. 2021 Jul 13. pii: 6319849. doi: 10.1093.
     PubMed    
     
     
     
103. ONO M, Garg S, Onuma Y, Serruys PW, et al
     Coronary artery bypass grafting versus percutaneous coronary intervention in ischaemic heart failure. Can reliable treatment decisions in high-risk patients be based on non-randomized data?
     Eur Heart J. 2021 Jul 1. pii: 6311994. doi: 10.1093.
     PubMed    
     
     
     May 2021
104. BULLUCK H, Paradies V, Barbato E, Baumbach A, et al
     Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardio
     Eur Heart J. 2021 May 31. pii: 6290281. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. VOLZ S, Redfors B, Angeras O, Ioanes D, et al
     Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
     Eur Heart J. 2021 May 23. pii: 6282431. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. CHIN CY, Huang SC, Wang JK, Chen CA, et al
     A bleeding Blalock-Taussig shunt.
     Eur Heart J. 2021;42:2022.
     PubMed    
     
     
     
107. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
     The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
     Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. LANSKY A, Chun H, Pietras C, Hussain Y, et al
     Refining drug-eluting stent technologies: from engineering to basic science.
     Eur Heart J. 2021;42:1770-1772.
     PubMed    
     
     
     April 2021
109. BODEN WE, Stone PH
     To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
     Eur Heart J. 2021;42:1394-1400.
     PubMed    
     
     
     
110. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
     The association between coronary graft patency and clinical status in patients with coronary artery disease.
     Eur Heart J. 2021;42:1433-1441.
     PubMed     Abstract available
     
     
     
111. DING D, Huang J, Westra J, Cohen DJ, et al
     Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.
     Eur Heart J. 2021 Apr 5. pii: 6211340. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2021
112. VITALE N, Lucarelli K, Di Bari N, Milano AD, et al
     Anomalous origin of a grafted left internal mammary artery from the deep brachial artery.
     Eur Heart J. 2021;42:1182.
     PubMed    
     
     
     
113. MARENZI G, Cosentino N, Cardinale D
     Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
     Eur Heart J. 2021;42:1035-1037.
     PubMed    
     
     
     
114. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
     Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
     Eur Heart J. 2021;42:1019-1034.
     PubMed     Abstract available
     
     
     
115. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
     Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
     Eur Heart J. 2021;42:1051.
     PubMed    
     
     
     February 2021
116. SCHOENRATH F, Just IA, Falk V, Emmert MY, et al
     Antiplatelet and direct oral anticoagulation management after coronary artery bypass graft surgery: the Cinderella of current cardiovascular trials, please show me (some) evidence.
     Eur Heart J. 2021 Feb 22. pii: 6146041. doi: 10.1093.
     PubMed    
     
     
     
117. CAO D, Baber U, Mehran R
     Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention.
     Eur Heart J. 2021 Feb 22. pii: 6146039. doi: 10.1093.
     PubMed    
     
     
     
118. LIUZZO G, Patrono C
     When less is more: dual antiplatelet therapy in elective percutaneous coronary intervention.
     Eur Heart J. 2021 Feb 8. pii: 6130737. doi: 10.1093.
     PubMed    
     
     
     January 2021
119. SEMERANO A, Saliou G, Sanvito F, Genchi A, et al
     Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy.
     Eur Heart J. 2021 Jan 31. pii: 6124843. doi: 10.1093.
     PubMed    
     
     
     
120. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
     Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
     Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
     PubMed     Abstract available
     
     
     
121. LUNARDI M, Onuma Y, Serruys PW
     Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
     Eur Heart J. 2021 Jan 27. pii: 6121205. doi: 10.1093.
     PubMed    
     
     
     
122. VRACHATIS DA, Giannopoulos GV, Deftereos SG
     Colchicine administered early in acute myocardial infarction: ready, set ... go?
     Eur Heart J. 2021 Jan 22. pii: 6106966. doi: 10.1093.
     PubMed    
     
     
     
123. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
     Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions
     Eur Heart J. 2021;42:298-307.
     PubMed     Abstract available
     
     
     
124. BERGMARK BA, Morrow DA
     Cardiac troponin elevation after elective PCI: adding infarct to major injury.
     Eur Heart J. 2021;42:335-338.
     PubMed    
     
     
     
125. O'DONOGHUE ML, Sabatine MS
     Aspirin or P2Y12 inhibition: establishing the cornerstone of antiplatelet therapy after stenting.
     Eur Heart J. 2021;42:320-322.
     PubMed    
     
     
     
126. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
     First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
     Eur Heart J. 2021;42:357.
     PubMed    
     
     
     
127. GUPTA A, Chhikara S
     Significant pinching of dominant left circumflex artery during provisional left main bifurcation angioplasty: what next?
     Eur Heart J. 2021;42:285.
     PubMed    
     
     
     
128. DAVIES A, Fox K, Galassi AR, Banai S, et al
     Management of refractory angina: an update.
     Eur Heart J. 2021;42:269-283.
     PubMed     Abstract available
     
     
     
129. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
     Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
     Eur Heart J. 2021;42:287.
     PubMed    
     
     
     
130. NICHOLLS M
     The Year in Cardiovascular Medicine 2020: Coronary Intervention.
     Eur Heart J. 2021 Jan 17. pii: 6103209. doi: 10.1093/eurheartj/ehaa1021.
     PubMed    
     
     
     
131. HOLT A, Blanche P, Zareini B, Rajan D, et al
     Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
     Eur Heart J. 2021 Jan 11. pii: 6082772. doi: 10.1093/eurheartj/ehaa1058.
     PubMed     Abstract available
     
     
     December 2020
132. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
     Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
     Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. CORTESE F, Magli M, Di Marino S
     A floating thrombus in the ascending aorta, as a complication of a percutaneous coronary angiography.
     Eur Heart J. 2020 Dec 14. pii: 6034852. doi: 10.1093/eurheartj/ehaa1001.
     PubMed    
     
     
     
134. GIACOPPO D, Matsuda Y, Fovino LN, D'Amico G, et al
     Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized cl
     Eur Heart J. 2020 Dec 7. pii: 6025040. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2020
135. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
     Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
     Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. PATRONO C, Galiuto L
     Weak hypothesis? Wrong pharmacologic tool? Inadequate experimental design? Comment on the ATPCI trial.
     Eur Heart J. 2020;41:4166-4167.
     PubMed    
     
     
     
137. GUO TT, Tan JS, Wu Y, Gao X, et al
     Balloon pulmonary angioplasty with distal embolic protection device for chronic thromboembolic pulmonary hypertension.
     Eur Heart J. 2020 Nov 12. pii: 5979515. doi: 10.1093.
     PubMed    
     
     
     
138. VERDECCHIA P, Angeli F, Cavallini C
     Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
     Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
     PubMed    
     
     
     October 2020
139. FANAROFF AC, Lopes RD
     Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy.
     Eur Heart J. 2020 Oct 25. pii: 5939783. doi: 10.1093.
     PubMed    
     
     
     
140. CHEN SL
     In the face of cunning enemy: DK crush writes legend.
     Eur Heart J. 2020;41:3763-3764.
     PubMed    
     
     
     
141. STOREY RF
     The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
     Eur Heart J. 2020;41:3546-3548.
     PubMed    
     
     
     
142. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
     Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
     Eur Heart J. 2020;41:3533-3545.
     PubMed     Abstract available
     
     
     September 2020
143. WALTERSCHEID B, Nguyen J, Tarbox M, Eshak N, et al
     Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention.
     Eur Heart J. 2020 Sep 4. pii: 5901663. doi: 10.1093.
     PubMed    
     
     
     August 2020
144. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
     Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
     Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2020
145. SADEGHI AH, Taverne YJHJ, Bogers AJJC, Mahtab EAF, et al
     Immersive virtual reality surgical planning of minimally invasive coronary artery bypass for Kawasaki disease.
     Eur Heart J. 2020 Jul 8. pii: 5868577. doi: 10.1093.
     PubMed    
     
     
     March 2020
146. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
     Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
     Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2020
147. ALLAHYARI A, Jernberg T, Hagstrom E, Leosdottir M, et al
     Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
     Eur Heart J. 2020 Feb 18. pii: 5739477. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. RYMER JA, Granger CB
     Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?
     Eur Heart J. 2020 Feb 7. pii: 5729984. doi: 10.1093.
     PubMed    
     
     
     
149. RAMASAMY A, Bajaj R, Choudry FA, Pugliese F, et al
     Intravascular ultrasound-guided management of ST-elevation myocardial infarction in a patient with lung cancer and myocardial metastasis.
     Eur Heart J. 2020 Feb 7. pii: 5729982. doi: 10.1093.
     PubMed    
     
     
     December 2019
150. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
     Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
     Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. KOGAME N, Serruys PW, Onuma Y
     Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
     Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
     PubMed    
     
     
     
152. KALLA M, Hao G, Tapoulal N, Tomek J, et al
     The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
     Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
     Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
     Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2019
154. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
     Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
     Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2019
155. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
     Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
     Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
     16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
     Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2019
157. PIAYDA K, Veulemans V, Kelm M, Zeus T, et al
     Transcaval aortic valve implantation through a partially thrombosed infrarenal aortic aneurysm.
     Eur Heart J. 2019 Mar 27. pii: 5420568. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Vascular Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: